Introduction into the course of infectious diseases. General description of group of intestinal infections. Typhoid fever. Paratyphoids A and B. Salmonellosis. Food poisoning.
http://intranet.tdmu.edu.ua/data/books/And-INF.pdf
Typhoid fever, paratyphoid A and B are an acute illnesses from the group of intestinal infections. They are characterized by cyclic course, bacteremia, intoxication, rash on the skin, lesions of the lymphatic apparatus of the small intestine. Besides that, typhoid fever is characterized by high fever of different duration, development of so-called status typhosus, hepatosplenomegaly, lesions of organs of the gastrointestinal tract, relapses and various complications.
http://www.cdc.gov/nczved/divisions/dfbmd/diseases/typhoid_fever/
History and geographical distribution
Typhoid fever is well known for a long time as an illness of mankind.
The causative agent of typhoid fever was described by Ebert in 1880. Pure culture of the agent was isolated by Gafki in 1884.
Typhoid fever was one of the most widespread and serious infectious disease in 19th century and in the beginning of 20-th century in all countries of the world, especially in the large towns due to groupment of the people and building of waterpipe and canalization allowed to decrease morbidity in the large towns. But almost every calamity (hunger, earthquake) and wars were accompanied by outbreaks of typhoid fever.
Now, the morbidity is sporadic in European countries. However, high level of morbidity occurs in some countries due to features of climate, ecological conditions and social factors (Mexico, India, Afghanistan, countries of Northern Africa and other).
http://www.medicinenet.com/typhoid_fever/article.htm
Etiology
The causative agent of typhoid is Salmonella typhi of Enterobacteriacea family, genus Salmonella, serological group D.
Salmonella are not-spore-forming rods and motile by peretrichous flagella (Fig.1). Like other enterobacteria, Salmonella have somatic (O) antigens which are lipopolysaccharide components of the cell wall and flagellar (H) antigens, which are proteins. There are approximately 60 O-antigens, which are designated by numbers at letters. The Kauffmann-White scheme categorizes Salmonella on the basis of somatic antigens, each group having a major determinant which is a strongly reaching somatic antigens and one or more major somatic antigen. Salmonella typhi also has a capsular or virulence (Vi) antigen composed of a homopolymer of N-acetyl galactosaminuronic acid. The presence of Vi-antigen on the cell surface may block agglutination by anti-O serum.
Fig.1. Salmonella typhi
Salmonella can be differentiated from other Enterobacteriaceae on basis of certain biochemical reactions, including fermentation. Most Salmonella ferment glucose and mannose to produce acid and gas but do not ferment lactose or sucrose; S.typhi does not produce gas. Thus, Salmonella typhi has some antigenic and biochemical features. That is why typhoid fever is isolated from the other diseases, caused by Salmonella. Salmonella organisms grow on the media with addition of bile. The resistance of agent of typhoid fever and paratyphoid in the environment is very high. They endure low temperatures very well. The agents of typhoid fever and paratyphoid diseases survive from 1-2 till 25-30 days, in food products.
Epidemiology
Typhoid fever is anthroponosis. The source of infection is sick man or bacteriocarrier. The patients with typhoid fever discharge the agent with stool, urine, rarely – with saliva and milk. The discharge of the agent is observed at the and of incubation period, during all disease, and sometimes in the period of reconvalescence. In some cases the discharge continues till three months (acute carriers) or more than three months (chronic carriers). Chronic carriers may be from six months till some years.
The mechanism of the infection transmission is fecal-oral. The factors of transmission may be water, milk, various food-stuffs and contaminated feces of the patient or bacterial carriers. Flies can play the supplementary role.
Susceptibility to agent of typhoid fever and paratyphoid diseases is rather high, however clinical manifestation can be of different grade. The care rate of typhoid fever and paratyphoid diseases depends on seasonal prevalence. It increases in summer-autumn period, due to consumption of a huge amount of flies, quite often from unknown sources, unwashed fruit and vegetables. The strong immunity develops after disease.
http://www.medicinenet.com/typhoid_fever/page2.htm
Pathogenesis
The next phases are distinguished in the pathogenesis of typhoid fever:
1. Penetration of the causative agent into the organism.
2. Development of lymphadenitis and lymphangitis.
3. Bacteremia
4. Intoxication.
5. Parenchymatous diffusion.
6. Discharge of the agent from the organism (excretory phase).
7. Allergic reaction, mainly, of lymphoid tissue of the small intestinum.
8. Formation of immunity.
The first phase is penetration of the agent in the macroorganism. However, penetration does not always lead to the development of the pathological process. It depends on the quantity of the agent and the state of barrier functions (stomach in this case). The further path of Salmonella typhi is lymphatic apparatus of intestine.
The second phase is lymphadenitis, lymphangitis. Salmonellae achieve the small intestine and actively penetrate into solitary follicules, Peyer’s patches. There is the reproduction of the agents and formation of the focus of infection. Microorganisms penetrate to regional lymphatic nodes (mesenterial) along the lymphatic patches. There is the other focus of infection. In the lymphatic apparatus, the typical morphological alterations with proliferation of tissue and formation the large typhoid cells develop.
Bacteria achieve the definite quantity and enter into the blood circulation through the thoracic duct. It is the next phase of pathogenesis – bacteremia. In clinic bacteremia means the end of incubation period and beginning of the clinical manifestations. The blood has bactericidal properties. It leads to the death of the part of microbes. Intoxicative syndrome develops. Intoxication is the fourth phase of pathogenesis. The action of endotoxins causes changes of the state of the central nervous system, adynamia, fever, headaches, violations of dream, appetite.
The fifth phase of a pathogenesis is parenchymatous diffusion of microbes. By the flow of the blood Salmonella of typhoid fever and paratyphoid also are delivered over the organism, enter into all organs. Microbes are fixated especially in liver, spleen, bone marrow, skin. Secondary focuses are formed (typhoid granulomas), from which bacteria likewise from the primary focuses (lymphatic apparatus of the intestine) enter into the blood, supporting bacteremia. The settling of microbes in the reticuloendothelial system and their destruction in the structures of reticuloendothelial system causes the cleaning of the organism from infection.
The sixth phase of pathogenesis is discharge of the agent from the organism. The agents enter into the intestine from the liver through the bile ducts. They are excreted into the external environment with feces of the patient. The part of the agents repeatedly penetrates from the small intestine into lymphatic apparatus of the intestine and cause sensibilization to microbes. The expressive changes of lymphoid tissue develop due to repeated implantation of Salmonella typhi with development of morphological changes from cerebral-like swelling to necrosis and formation of ulcers.
This process is considered as the seventh phase of pathogenesis – allergic response of lymphoid tissue of the small intestine.
Eighth phase of pathogenesis is formation of immunity and restoration of the physiological equilibrium.
All pathogenic Salmonella species are engulfed by phagocytic cells, which then pass them through the mucosa and present them to the macrophages in the lamina propria. Nontyphoidal salmonellae are phagocytized throughout the distal ileum and colon. With toll-like receptor (TLR)–5 and TLR-4/MD2/CD-14 complex, macrophages recognize pathogen-associated molecular patterns (PAMPs) such as flagella and lipopolysaccharides. Macrophages and intestinal epithelial cells then attract T cells and neutrophils with interleukin 8 (IL-8), causing inflammation and suppressing the infection.
In contrast to the nontyphoidal salmonellae, S typhi enters the host’s system primarily through the distal ileum. S typhi has specialized fimbriae that adhere to the epithelium over clusters of lymphoid tissue in the ileum (Peyer patches), the main relay point for macrophages traveling from the gut into the lymphatic system. S typhi has a Vi capsular antigen that masks PAMPs, avoiding neutrophil-based inflammation. The bacteria then induce their host macrophages to attract more macrophages.
S typhi co-opts the macrophages’ cellular machinery for its own reproduction as it is carried through the mesenteric lymph nodes to the thoracic duct and the lymphatics and then through to the reticuloendothelial tissues of the liver, spleen, bone marrow, and lymph nodes. Once there, the S typhi bacteria pause and continue to multiply until some critical density is reached. Afterward, the bacteria induce macrophage apoptosis, breaking out into the bloodstream to invade the rest of the body.
The bacteria then infect the gallbladder via either bacteremia or direct extension of S typhi –infected bile. The result is that the organism re-enters the gastrointestinal tract in the bile and reinfects Peyer patches. Bacteria that do not reinfect the host are typically shed in the stool and are then available to infect other hosts.
Risk factors
S typhi are able to survive a stomach pH as low as 1.5. Antacids, histamine-2 receptor antagonists (H2 blockers), proton pump inhibitors, gastrectomy, and achlorhydria decrease stomach acidity and facilitate S typhi infection.
HIV/AIDS is clearly associated with an increased risk of nontyphoidal Salmonella infection; however, the data and opinions in the literature as to whether this is true for S typhi infection are conflicting. If an association exists, it is probably minor.
Other risk factors for clinical S typhi infection include various genetic polymorphisms. These risk factors often also predispose to other intracellular pathogens. For instance, PARK2 and PACGR code for a protein aggregate that is essential for breaking down the bacterial signaling molecules that dampen the macrophage response. Polymorphisms in their shared regulatory region are found disproportionately in persons infected with Mycobacterium leprae and S typhi.
On the other hand, protective host mutations also exist. The fimbriae of S typhi bind in vitro to cystic fibrosis transmembrane conductance receptor (CFTR), which is expressed on the gut membrane. Two to 5% of white persons are heterozygous for the CFTR mutation F508del, which is associated with a decreased susceptibility to typhoid fever, as well as to cholera and tuberculosis. The homozygous F508del mutation in CFTR is associated with cystic fibrosis. Thus, typhoid fever may contribute to evolutionary pressure that maintains a steady occurrence of cystic fibrosis, just as malaria maintains sickle cell disease in Africa.
Life cycle of Salmonella typhi.
Environmental and behavioral risk factors that are independently associated with typhoid fever include eating food from street vendors, living in the same household with someone who has new case of typhoid fever, washing the hands inadequately, sharing food from the same plate, drinking unpurified water, and living in a household that does not have a toilet. As the middle class in south Asia grows, some hospitals there are seeing a large number of typhoid fever cases among relatively well-off university students who live in group households with poor hygeine. American clinicians should keep this in mind, as members of this cohort often come to the United States for higher degrees.
Pathological anatomy
Sequential changes in tissue in the ileocecal area of the intestinal tract occur during typhoid fever and have been classified into four phases:
1. hyperplasia;
2. necrosis and sloughing;
3. ulceration;
4. healing.
During the first week of clinical symptoms, hyperplastic changes occur in Peyer’s patches in the ileum and in lymphoid follicles in the cecum, causing there tissue to project into the bowel lumen. The hyperplasia regresses after 7-10 days or undergoes necrosis with sloughing of overlying mucosa leading to the formation of characteristic ulcers that parallel the long axis of the ileum (Fig.2). Small punctuate lesions develop in the cecum. Ulcers usually heal completely with little residual scarring, but they may be the sites of hemorrhage or may penetrate to the serosa and lead to bowel perforation.
Fig.2. Ulcers of ileum
Clinical manifestation
http://www.localhealth.com/article/typhoid-fever-1/symptoms
Typhoid fever and paratyphoid are characterized by cyclic course. There are such periods during course of the infectious process: incubation, initial, period of climax, early reconvalescence and outcomes.
The incubation period of typhoid fever is usually 10-14 days but it may be from 7 to 21 days. The incubation period is influenced by the number of organisms ingested. The duration of incubation period also depends on virulence of microorganism and state of macroorganism.
Manifestations of enterocolitis occasionally occur within hours after the ingestion of food or drink contaminated with S. typhi if the dose of organisms is large. In these instances symptoms of nausea, vomiting and diarrhea usually resolve completely before the onset of symptoms of typhoid fever.
The onset of typhoid fever is insidious in contrast to sepsis produced by most other gram-negative organisms. The initial manifestations are nonspecific and consist of fever, malaise, anorexia, headache and myalgias. Remittent fever is prominent with gradually increasing evening temperature elevations from less than 38 °C to values in the range of 40 °C by the end of the first week of illness.
The disease turns into the next stage (climax of the disease) at the end of the first week. The appearance of the patients is very typical in this period. The skin is pale. Patient is apathethic. Intoxication is increased. Temperature is constant and most typical syndrome of typhoid fever and paratyphoid. At first the temperature was described by Vunderlish in 19 century. Temperature curve riminds trapezium. The phase of increase of the temperature is near one week. The phase of climax is near two weeks. The phase of decrease of the temperature is near one week. Temperature curve of Vunderlish occurs rarely. Temperature curve has wave-like character more frequently (temperature curve of Botkin).
Chills and diaphoreses are seen in about one-third of the patient even in the absence of antimicrobial therapy. Either constipation or diarrhea may occur. Respiratory symptoms, including cough and sore throat may be prominent. Neuropsychiatries manifestations, including confusion, dizziness, seizures, or acute psychotic behavior, may be predominant in an occasional case. Status typhosus is observed in serious course of the disease.
In present time patient with typhoid fever usually appears acutely ill. Fever is usually prominent, and in many instances the pulse is slow relative to the temperature.
In typhoid fever symptoms of violation of cardiovascular system are constant and expressive. The basis of hemodynamic disorder is violation of the tonus of the vessels, damage of heart muscle due to intoxication. Myocardiodystrophy develops as a result. In typhoid fever relative bradycardia is the clinical feature of cardiovascular disorders. The muffed heart sounds, systolic murmur at the heart apex, hypotension are marked inrarely. Relative bradycardia develops due to endotoxin action of the agent on X pair of cerebrospinal nerves.
Rose spots, 2-4 mm erythematous, maculopapular lesions that blanch on pressure, appear on the upper abdomen or on the lateral surface of the body. Roseolas are few (5-15) iumber (Fig. 1). The lesions are transient and resolve in hours to days. Rose spots are observed on the 7-10 day of the disease near in half of patients. Sometimes they dissapears, sometimes exist longer than fever.
Cervical lymphoadenopathy may be present. Examination of the chest may reveal moist rales. The abdomen is tender, especially in the lower quadrants. Abdominal distention is common, and peristalsis is often hypoactive. The sensation of displacing air – and fluid-filled loops of bowel on palpating of the abdomen is considered to be characteristic. In percussion short sound is marked in ileocaecal area due to enlarged mesenteric lymphatic nodes (Padalka symptom).
Fig.3. Rose spots
Hepatomegaly is noted in about 40-50 % of the patient, and a soft, tender spleen can be palpated in about 40-60 %. In about 10 % of the patients, changes in consciousness are present and manifest as lethargy, delirium, or coma.
Without antimicrobial therapy, the disease pursues a prolonged course with slow resolution of signs and symptoms 3-4 weeks after onset if there are no complications. Sustained fever is common during the second and third weeks of disease. Fever decreases slowly by lysis, unlike the resolution by crisis seen in the preantibiotic era in many cases of pneumococcal pneumonia. Headache, confusion, respiratory symptoms, and abdominal pain and distention gradually resolve, and the pulse more characteristically reflects degree of fever acute manifestations subsiding. Profound weight loss invariably occurs in untreated patient. Many of the complications of typhoid fever occur during the period of resolution in the third or fourth week after onset.
Complications
Complications of typhoid fever can be classified as secondary to toxemia (myocarditis, hyperpyrexia, hepatic and bone marrow damage), secondary to local gastrointestinal lesions (haemorrhage and perforation), secondary to prolonged severe illness (suppurative parotitis decubiti, and pneumonia), secondary to growth and persistence of typhoid fever bacilli (relapse, localized infection – meningitis, endocarditis, osteomyelitis or arthritis – and secondary to therapy (bone marrow suppression, hypersensitive reactions and toxic shock).
In the preantimicrobial era, 12-16 % of the patients with typhoid fever died, frequently from complications in the third or fourth week of the disease. Fatalities still occur occasionally, probably in less than one percent of the patients receiving appropriate antimicrobial and pathogenetic therapy. However, in certain specific geographic areas of Indonesia, India, and Nigeria, fatality rations of 9-32 % have been reported last 10-15 years. It is likely that these results are consequent to suboptimal health and medical care rather that an increase in the clinical severity of typhoid fever.
The complications attributed to “toxemia” might be considered as manifestations of severe disease. Toxic myocarditis occur in severely ill patients, frequently children, and is manifested by tachycardia, weak pulse, muffled heart sounds, and hypotension. The electrocardiogram shows low voltage and T-wave flattening or inversion. Atrial or ventricular arrhythmia may occur.
Major intestinal hemorrhage is usually a late complication that occur during the second or third week of illness. In the preantimicrobial era, gross intestinal hemorrhage occurred in about 5-7 % of the patient with typhoid fever. The incidence of hemorrhage requiring transfusions has been reduced to 1 or 2 %, due to chloramphenicol use. There is an important sign of the massive intestinal hemorrhage symptom of “scissors” (Fig.4). Suddenly the temperature is decreased up to normal or subnormal. But tachycardia is observed. The arterial pressure is reduced. Intestinal perforation usually occurs during third week of illness. Perforation occurs in the terminal ileum where the number of lymphoid aggregates is the largest and ulcerations most frequent. In general, perforation has reported in recent years in one percent or less of cases as compared with 2-5 % in several series collected in the preantibiotic era.
Fig.4. Decreasing of temperature and tachycardia (“scissors” symptom)
Relapse, a recurrence of the manifestation of typhoid fever after initial clinical response, occur in about 8-12 % of the patient who have not received antimicrobial therapy. The relapse rate was found to be doubled in patients receiving chloramphenicol therapy for 2 weeks. Ampicillin probably does not affect the rate of relapse.
Localization of infection, which may lead to abscess formation, can occur in almost any organ or tissue. Although bacteremia can be assumed to develop in all patient with typhoid fever, localized infections such as meningitis, endocarditis, osteomyelitis, or thyroiditis occur in less then one percent.
The chronic carrier state is detained as documented excretion of S. typhi in stool or urine for a year or more. The chronic carrier state usually follows typhoid fever but as many as one – third of the chronic carriers give no history consistent with this illness. Underlying biliary or urinary tract diseases, especially with stone formation, increase the probability of the chronic enteric or urinary carrier state in patients with typhoid fever. One to 3 % of the patients with typhoid fever become chronic enteric carriers; however, the incidence is higher in older patients (at the sixth decade) and in women.
http://www.nlm.nih.gov/medlineplus/ency/article/001332.htm
Clinical features of paratyphoids
Epidemiology, pathogens, morphology and clinics of paratyphoid A and B, have, in principal, mutual signs with typhoid fever. However, paratyphoids have some clinical features.
In paratyphoid A incubation period is shorter than in typhoid fever. It’s duration is 8-10 days. The onset of the disease is an acute. Sometimes, the onset of the disease is accompanied by cough, catarrh. Facial hyperemia, blood injection of the sclera’s vessels, herpes on the lips are observed during examination. The temperature is wave-like or remittent. The fever is accompanied by chills and than by diaphoreses. In paratyphoid A the rash appeares in more early periods than in typhoid fever. The rash is polymorphic. Roseolas, petechias and measles-like rash may be observed. The intoxication is temperate. There is no status typhosus. There is normal quantity of leukocytes in peripheral blood. But leukocytosis and lymphocytosis may occur too.
In majority of the patients the disease has a moderate course. But the severe forms may be observed too, with complications (intestinal hemorrhage, intestinal perforation and other). The relapses are frequently observed in case of paratyphoid A.
Paratyphoid B incubation period is 5-10 days. The onset of the disease is acute, with expressive chill, myalgia and diaphoreses. At the initial period of the disease the intoxication may be combined with symptoms of acute gastroenteritis. The temperature is not prolonged. Status typhosus is absent in majority of the patients. The symptoms of intoxication disappeares very quickly. The rash is polymorphic, plenty. It appears at the earlier period. In some cases the course of paratyphoid B may be severe with septic manifestations (purulent meningitis, meningoencephalitis, septicopyemia). In peripheral blood leukocytosis and neutrophylosis are observed.
Diagnosis
Definitive diagnosis of typhoid fever and paratyphoid is made on the basis of pathogen isolation from the patient’s blood. Isolation of the organism from stool, especially in endemic areas, does constitute strong presumptive evidence of typhoid fever in the patient with a typical clinical course. Serologic studies may be helpful, but in many cases of typhoid fever there is no increase in titer of agglutinins during the course of infection, and other illnesses, especially infections with other gram – negative bacilli, may cause nonspecific elevations of agglutinins because of cross – reaching antigens. In untreated disease only about 50 % of the patient have a fourfold or greater increase in titer of agglutinins (Vidal’s test) against typhoid fever O antigen at any time during the course of disease.
The diagnosis of typhoid fever (enteric fever) is primarily clinical.
Importantly, the reported sensitivities of tests for S typhi vary greatly in the literature, even among the most recent articles and respected journals.
- Culture
- The criterion standard for diagnosis of typhoid fever has long been culture isolation of the organism. Cultures are widely considered 100% specific.
- Culture of bone marrow aspirate is 90% sensitive until at least 5 days after commencement of antibiotics. However, this technique is extremely painful, which may outweigh its benefit.
- Blood, intestinal secretions (vomitus or duodenal aspirate), and stool culture results are positive for S typhi in approximately 85%-90% of patients with typhoid fever who present within the first week of onset. They decline to 20%-30% later in the disease course. In particular, stool culture may be positive for S typhi several days after ingestion of the bacteria secondary to inflammation of the intraluminal dendritic cells. Later in the illness, stool culture results are positive because of bacteria shed through the gallbladder.
- Multiple blood cultures (>3) yield a sensitivity of 73%-97%. Large-volume (10-30 mL) blood culture and clot culture may increase the likelihood of detection.
- Stool culture alone yields a sensitivity of less than 50%, and urine culture alone is even less sensitive. Cultures of punch-biopsy samples of rose spots reportedly yield a sensitivity of 63% and may show positive results even after administration of antibiotics. A single rectal swab culture upon hospital admission can be expected to detect S typhi in 30%-40% of patients. S typhi has also been isolated from the cerebrospinal fluid, peritoneal fluid, mesenteric lymph nodes, resected intestine, pharynx, tonsils, abscess, and bone, among others.
- Bone marrow aspiration and blood are cultured in a selective medium (eg, 10% aqueous oxgall) or a nutritious medium (eg, tryptic soy broth) and are incubated at 37°C for at least 7 days. Subcultures are made daily to one selective medium (eg, MacConkey agar) and one inhibitory medium (eg, Salmonella-Shigella agar). Identification of the organism with these conventional culture techniques usually takes 48-72 hours from acquisition.
Table 2. Sensitivities of Cultures
|
Incubation |
Week 1 |
Week 2 |
Week 3 |
Week 4 |
Bone marrow aspirate (0.5-1 mL) |
|
90% (may decrease after 5 d of antibiotics) |
|||
Blood (10-30 mL), stool, or duodenal aspirate culture |
40%-80% |
~20% |
Variable (20%-60%) |
||
Urine |
|
25%-30%, timing unpredictable |
- Polymerase chain reaction (PCR): PCR has been used for the diagnosis of typhoid fever with varying success. Nested PCR, which involves two rounds of PCR using two primers with different sequences within the H1-d flagellin gene of S typhi, offers the best sensitivity and specificity. Combining assays of blood and urine, this technique has achieved a sensitivity of 82.7% and reported specificity of 100%. However, no type of PCR is widely available for the clinical diagnosis of typhoid fever.
- Specific serologic tests
- Assays that identify Salmonella antibodies or antigens support the diagnosis of typhoid fever, but these results should be confirmed with cultures or DNA evidence.
- The Widal test was the mainstay of typhoid fever diagnosis for decades. It is used to measure agglutinating antibodies against H and O antigens of S typhi. Neither sensitive nor specific, the Widal test is no longer an acceptable clinical method.
- Indirect hemagglutination, indirect fluorescent Vi antibody, and indirect enzyme-linked immunosorbent assay (ELISA) for immunoglobulin M (IgM) and IgG antibodies to S typhi polysaccharide, as well as monoclonal antibodies against S typhi flagellin, are promising, but the success rates of these assays vary greatly in the literature.
- Other nonspecific laboratory studies
- Most patients with typhoid fever are moderately anemic, have an elevated erythrocyte sedimentation rate (ESR), thrombocytopenia, and relative lymphopenia.
- Most also have a slightly elevated prothrombin time (PT) and activated partial thromboplastin time (aPTT) and decreased fibrinogen levels.
- Circulating fibrin degradation products commonly rise to levels seen in subclinical disseminated intravascular coagulation (DIC).
- Liver transaminase and serum bilirubin values usually rise to twice the reference range.
- Mild hyponatremia and hypokalemia are common.
- A serum alanine amino transferase (ALT)–to–lactate dehydrogenase (LDH) ratio of more than 9:1 appears to be helpful in distinguishing typhoid from viral hepatitis. A ratio of greater than 9:1 supports a diagnosis of acute viral hepatitis, while ratio of less than 9:1 supports typhoid hepatitis.
Differential diagnosis
The differential diagnosis of typhoid fever requires consideration of many disease processes characterized by fever and abdominal complaints.
Early in the disease the predominance of fever and upper respiratory tract symptoms may suggest influenza or other viral infections. Cough and fever suggest acute bronchitis and, when coupled with rales, raise the question of bacterial pneumonia. Headache, confusion, and fever may prompt consideration of bacterial or aseptic meningitis or meningoencephalitis. Delirium, catatonia, or coma may suggest a diagnosis of psychosis or other neuropsychiatries illness. The abdominal findings may lead to a consideration of acute appendicitis, acute cholecystitis, or intestinal infarction. Bacillary, amebic or ischemic colitis may enter the differential diagnosis if blood diarrhea occurs. As fever continues over a period of weeks, other possibilities might include brucellosis, yersinosis, lymphoma, inflammatory bowel disease, bacterial endocarditis, miliary tuberculosis, malaria, sepsis, epidemic typhus and many other diseases.
Treatment
http://emedicine.medscape.com/article/231135-medication
Antibiotics
Class Summary
Definitive treatment of typhoid fever (enteric fever) is based on susceptibility. As a general principle of antimicrobial treatment, intermediate susceptibility should be regarded as equivalent to resistance. Between 1999 and 2006, 13% of S typhi isolates collected in the United States were multidrug resistant.
Until susceptibilities are determined, antibiotics should be empiric, for which there are various recommendations. The authors of this article consider the 2003 World Health Organization (WHO) guidelines to be outdated. These recommend fluoroquinolone treatment for both complicated and uncomplicated cases of typhoid fever, but 38% of S typhi isolates taken in the United States in 2006 were fluoroquinolone resistant (nalidixic acid–resistant S typhi [NARST]), and the rate of multidrug resistance was 13%. (Multidrug-resistant S typhi is, by definition, resistant to the original first-line agents, ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole.)
The particular sensitivity pattern of the organism in its area of acquisition should be the major basis of empiric antibiotic choice. It may soon become necessary to treat all cases presumptively for multidrug resistance until sensitivities are obtained.
Note that nalidixic acid is a nontherapeutic drug that is used outside of the United States as a stand-in for fluoroquinolones in sensitivity assays. In the United States, it is still used specifically for S typhi infection.
History of antibiotic resistance
Chloramphenicol was used universally to treat typhoid fever from 1948 until the 1970s, when widespread resistance occurred. Ampicillin and trimethoprim-sulfamethoxazole (TMP-SMZ) then became treatments of choice. However, in the late 1980s, some S typhi and S paratyphi strains (multidrug resistant [MDR] S typhi or S paratyphi) developed simultaneous plasmid-mediated resistance to all three of these agents.
Fluoroquinolones are now recommended by most authorities for the treatment of typhoid fever. They are highly effective against susceptible organisms, yielding a better cure rate than cephalosporins. Unfortunately, resistance to first-generation fluoroquinolones is widespread in many parts of Asia.
In recent years, third-generation cephalosporins have been used in regions with high fluoroquinolone resistance rates, particularly in south Asia and Vietnam. Unfortunately, sporadic resistance has been reported, so it is expected that these will become less useful over time.
Mechanisms of antibiotic resistance
The genes for antibiotic resistance in S typhi and S paratyphi are acquired from Escherichia coli and other gram-negative bacteria via plasmids. The plasmids contain cassettes of resistance genes that are incorporated into a region of the Salmonella genome called an integron. Some plasmids carry multiple cassettes and immediately confer resistance to multiple classes of antibiotics. This explains the sudden appearance of MDR strains of S typhi and S paratyphi, often without intermediate strains that have less-extensive resistance.
The initial strains of antibiotic-resistant S typhi and S paratyphi carried chloramphenicol acetyltransferase type I, which encodes an enzyme that inactivates chloramphenicol via acetylation. MDR strains may carry dihydrofolate reductase type VII, which confers resistance to trimethoprim. Interestingly, in areas where these drugs have fallen out of use, S typhi has reverted to wild type, and they are often more effective thaewer agents.
Resistance to fluoroquinolones is evolving in an ominous direction. Fluoroquinolones target DNA gyrase and topoisomerase IV, bacterial enzymes that are part of a complex that uncoils and recoils bacterial DNA for transcription. S typhi most commonly develops fluoroquinolone resistance through specific mutations in gyrA and parC, which code for the binding region of DNA gyrase and topoisomerase IV, respectively.
A single point mutation gyrA confers partial resistance. If a second gyrA point mutation is added, the resistance increases somewhat. However, a mutation in parC added to a single gyrA mutation confers full in vitro resistance to first-generation fluoroquinolones. Clinically, these resistant strains show a 36% failure rate when treated with a first-generation fluoroquinolone such as ciprofloxacin. The risk of relapse after bacterial clearance is higher in both partially and fully resistant strains than in fully susceptible strains.
The third-generation fluoroquinolone gatifloxacin appears to be highly effective against all known clinical strains of S typhi both in vitro and in vivo. due to its unique interface with gyrA. It achieves better results than cephalosporins even among strains that are considered fluoroquinolone resistant. However, gatifloxacin is no longer on the market in the United States, and its use cannot be generalized to any other member of the class.
In any case, as gatifloxacin replaces older fluoroquinolones in high-prevalence resistance is bound to emerge. Any two of a number of gyrA mutations, when added to the parC mutation, confer full in vitro resistance. Although such a combination has yet to be discovered in vivo, all of these mutations exist in various clinic strains, and it seems highly likely that a gatifloxacin-resistant one will be encountered clinically if selective pressure with fluoroquinolones continues to be exerted.
Geography of resistance
Among S typhi isolates obtained in the United States between 1999 and 2006, 43% were resistant to at least one antibiotic.
Nearly half of S typhi isolates found in the United States now come from travelers to the Indian subcontinent, where fluoroquinolone resistance is endemic (see Table 3). The rate of fluoroquinolone resistance in south and Southeast Asia and, to some extent, in East Asia is generally high and rising (see Table 3). Susceptibility to chloramphenicol, TMP-SMZ, and ampicillin in South Asia is rebounding. In Southeast Asia, MDR strains remain predominant, and some acquired resistance to fluoroquinolones by the early 2000s.
The most recent professional guideline for the treatment of typhoid fever in south Asia was issued by the Indian Association of Pediatrics (IAP) in October 2006. Although these guidelines were published for pediatric typhoid fever, the authors feel that they are also applicable to adult cases. For empiric treatment of uncomplicated typhoid fever, the IAP recommends cefixime and, as a second-line agent, azithromycin. For complicated typhoid fever, they recommend ceftriaxone. Aztreonam and imipenem are second-line agents for complicated cases. The authors believe that the IAP recommendations have more validity than the WHO recommendations for empiric treatments of typhoid fever in both adults and children.
In high-prevalence areas outside the areas discussed above, the rate of intermediate sensitivity or resistance to fluoroquinolones is 3.7% in the Americas (P =.132), 4.7% (P =.144) in sub-Saharan Africa, and 10.8% (P =.706) in the Middle East. Therefore, for strains that originate outside of south or Southeast Asia, the WHO recommendations may still be valid—that uncomplicated disease should be treated empirically with oral ciprofloxacin and complicated typhoid fever from these regions should be treated with intravenous ciprofloxacin.
Antibiotic resistance is a moving target. Reports are quickly outdated, and surveys of resistance may have limited geographic scope. Therefore, any recommendation regarding antibiotic treatment must be taken with a grain of salt. In the authors’ opinion, if the origin of the infection is unknown, the combination of a first-generation fluoroquinolone and a third-generation cephalosporin should be used.
Table 3. Antibiotic Recommendations by Origin and Severity
Location |
Severity |
First-Line Antibiotics |
Second-Line Antibiotics |
South Asia, East Asia
|
Uncomplicated |
Cefixime PO |
Azithromycin PO |
Complicated |
Ceftriaxone IV or |
Aztreonam IV or |
|
Eastern Europe, Middle East, sub-Saharan Africa, South America |
Uncomplicated |
Ciprofloxacin PO or |
Cefixime PO or Amoxicillin PO or |
Complicated |
Ciprofloxacin IV or |
Ceftriaxone IV or |
|
Unknown geographic origin or Southeast Asia |
Uncomplicated |
Cefixime PO plus |
Azithromycin PO* |
Complicated |
Ceftriaxone IV or |
Aztreonam IV or |
|
*Note that the combination of azithromycin and fluoroquinolones is not recommended because it may cause QT prolongation and is relatively contraindicated. |
Future directions
A meta-analysis found that azithromycin appeared to be superior to fluoroquinolones and ceftriaxone with lower rates of clinical failure and relapse respectively. Although the data did not permit firm conclusions, if further studies confirm the trend, azithromycin could become a first-line treatment.
Chloramphenicol (Chloromycetin)
Binds to 50S bacterial-ribosomal subunits and inhibits bacterial growth by inhibiting protein synthesis. Effective against gram-negative and gram-positive bacteria. Since its introduction in 1948, has proven to be remarkably effective for enteric fever worldwide. For sensitive strains, still most widely used antibiotic to treat typhoid fever. In the 1960s, S typh i strains with plasmid-mediated resistance to chloramphenicol began to appear and later became widespread in many endemic countries of the Americas and Southeast Asia, highlighting need for alternative agents.
Produces rapid improvement in patient’s general condition, followed by defervescence in 3-5 d. Reduced preantibiotic-era case-fatality rates from 10%-15% to 1%-4%. Cures approximately 90% of patients. Administered PO unless patient is nauseous or experiencing diarrhea; in such cases, IV route should be used initially. IM route should be avoided because it may result in unsatisfactory blood levels, delaying defervescence.
Amoxicillin (Trimox, Amoxil, Biomox)
Interferes with synthesis of cell wall mucopeptides during active multiplication, resulting in bactericidal activity against susceptible bacteria. At least as effective as chloramphenicol in rapidity of defervescence and relapse rate. Convalescence carriage occurs less commonly than with other agents when organisms are fully susceptible. Usually given PO with a daily dose of 75-100 mg/kg tid for 14 d.
Trimethoprim and sulfamethoxazole (Bactrim DS, Septra)
Inhibits bacterial growth by inhibiting synthesis of dihydrofolic acid. Antibacterial activity of TMP-SMZ includes common urinary tract pathogens, except Pseudomonas aeruginosa. As effective as chloramphenicol in defervescence and relapse rate. Trimethoprim alone has been effective in small groups of patients.
Ciprofloxacin (Cipro)
Fluoroquinolone with activity against pseudomonads, streptococci, MRSA, Staphylococcus epidermidis, and most gram-negative organisms but no activity against anaerobes. Inhibits bacterial DNA synthesis and, consequently, growth. Continue treatment for at least 2 d (7-14 d typical) after signs and symptoms have disappeared. Proven to be highly effective for typhoid and paratyphoid fevers. Defervescence occurs in 3-5 d, and convalescent carriage and relapses are rare. Other quinolones (eg, ofloxacin, norfloxacin, pefloxacin) usually are effective. If vomiting or diarrhea is present, should be given IV. Fluoroquinolones are highly effective against multiresistant strains and have intracellular antibacterial activity.
Not currently recommended for use in children and pregnant women because of observed potential for causing cartilage damage in growing animals. However, arthropathy has not been reported in children following use of nalidixic acid (an earlier quinolone known to produce similar joint damage in young animals) or in children with cystic fibrosis, despite high-dose treatment.
Cefotaxime (Claforan)
Arrests bacterial cell wall synthesis, which inhibits bacterial growth. Third-generation cephalosporin with gram-negative spectrum. Lower efficacy against gram-positive organisms. Excellent in vitro activity against S typhi and other salmonellae and has acceptable efficacy in typhoid fever. Only IV formulations are available. Recently, emergence of domestically acquired ceftriaxone-resistant Salmonella infections has been described.
Azithromycin (Zithromax)
Treats mild to moderate microbial infections. Administered PO at 10 mg/kg/d (not exceeding 500 mg), appears to be effective to treat uncomplicated typhoid fever in children 4-17 y. Confirmation of these results could provide an alternative for treatment of typhoid fever in children in developing countries, where medical resources are scarce.
Ceftriaxone (Rocephin)
Third-generation cephalosporin with broad-spectrum gram-negative activity against gram-positive organisms; Excellent in vitro activity against S typhi and other salmonellae.
Cefoperazone (Cefobid)
Discontinued in the United States. Third-generation cephalosporin with gram-negative spectrum. Lower efficacy against gram-positive organisms.
Ofloxacin (Floxin)
A pyridine carboxylic acid derivative with broad-spectrum bactericidal effect.
Levofloxacin (Levaquin)
For pseudomonal infections and infections due to multidrug-resistant gram-negative organisms.
Prophylaxis
http://www.cdc.gov/nczved/divisions/dfbmd/diseases/typhoid_fever/#avoidance
Control of Salmonella typhi infection transmitted from person to person depends on high standards of personal hygiene, maintenance of a supply of uncontaminated water, proper sewage dispose and identification, treatment, and follow-up of chronic carriers. Hand washing is of paramount importance in controlling person – to person spread although hands of convalescent carriers are often contaminated after defecation detectable Salmonella are easily removed by washing the hands with soap and water.
Typhoid fever vaccine, a saline suspension of aceton or heat/phenol killed S. typhi enhances the resistance of human beings to infection with S. typhi under experimental and natural conditions. Vaccine efficacy ranges from 51 to 67 %.
There is also renewed interest in testing the capsular polysaccharide of S. typhi (Vi antigen) as a parenteral typhoid fever vaccine.
Typhoid fever vaccine should be considered for persons with intimate continuing exposure to a documented typhoid fever carrier and for persons traveling to areas where there is a recognized appreciable risk to exposure to typhoid fever.
Salmonellosis
Salmonellae are widely dispersed in nature, being found in the in the gastrointestinal tracts of domesticated and wild mammals, reptiles, birds, and insects.
May present clinically as gastroenteritis, enteric fever, a bacteremic syndrome, or focal disease. An asymptomatic carrier state may also occur.
http://www.cdc.gov/salmonella/
Historic reference
The term “Salmonellosis” unites a large group of diseases, caused by multiply serotypes of bacteriums from genus Salmonellae (more than 2000).
Sallmonellae are named for the pathologist Salmon who first isolated S. cholerae suis from porcine intestine. The antigenic classification or serotyping of Salmonella used today is the result of study of antibody interactions with bacterial surface antigens by Kauffman and White in the 1920s to 1940s.
Salmonellosis is disease of animals and humans. It is characterized by essential damage of gastrointestinal tract, and more rarely by typhus-like or septicopyemic duration.
Etiology
http://www.onlinemedicinetips.com/disease/s/salmonella/Etiology-Of-Salmonella.html
Salmonella are non-spore-forming gram negative rods of the family Enterobacteriaceae. Salmonella are motile by peritrichous flagella. Salmonella strains demonstrate sufficient differences in biochemical reactions, antigenic structure, host adaptations, and geographical distribution to be grouped into 10 distinct subgroups, which have been variously designated in proposed taxonomic schemes. Virtually all strains isolated in clinical laboratories and implicated in disease in humans (more than 700 serotypes)(Fig.9).
Fig.9. Lactose-negative colonies of salmonella growing on MacConkey agar
Like other enterobacteria, salmonella has somatic (0) antigens, which are lipopolysaccharide components of the cell wall, and flagella (H) antigens, which are proteins. There may be detached some serological groups on the basic of the differences in structure of O-antigens. Salmonella preserve viability in external environment for a long time: in water – 11-120 days, in the sea water – 15-27 days, in soil – 1-9 months , in sausage products – 60-130 days, in the eggs, vegetables and fruits till 2,5 months. The optimal temperature for reproduction is 35-37 °C. There are serological groups A, B, C, D, E and other.
Salmonella can be differentiated from other Enterobacteriaceae on the basis of certain biochemical reactions, including fermentation reactions with specific sugars.
Salmonella organisms grow readily on simple media in aerobic or anaerobic conditions. Cultures of specimens that are normally sterile, such as blood, joint fluid, or cerebrospinal fluid, can be done on ordinary media such as blood agar. Excretions or secretions, such as feces or sputum, which have high concentrations of other microorganisms, are usually grown on selective or differential media, such as bismuth sulfate agar or desoxychlorate agar, which contains inhibitors of growth of non-pathogenic organisms of the normal flora.
Epidemiology
http://www.safe–poultry.com/salmonellaepidemiology.asp
Animals suffering from primary or secondary salmonellosis, water swimming birds and also human-sick or carries are the main sources of infection in salmonellosis. Mechanism of transmission of infection is fecal-oral. The factors of the transmission of the infection are food-stuffs of animal origin and other products which are polluted by excretions of animals and humans. The promotive factors are violation of the preservation and preparing of the food and also sanitary.
The diseases occur as separate sporadic cases and as outbreaks. Susceptibility of human depends from the premorbidal state of the macroorganism and from the quantity and variety (serotypes) of Salmonella.
Salmonella are primarily pathogens of lower animals. The reservoir of infection in animals constitutes the principal source of nontyphoidal Salmonella organisms that infect man, although infection may be transmitted from person to person, Salmonella have been isolated from almost all animals species, including poultry (chickens, turkeys and ducks), cows, pigs, pets (turtles, cats, dogs, mice, guinea pigs and hamsters), other birds (doves, pigeons, parrots, starlings, sparrows), sheep, seals, donkeys, lizards and snakes.
The most accurate information on sources of human Salmonellosis is derived from studies of outbreaks. Poultry (chickens, turkeys, ducks) and poultry products (primarily eggs) are the most important sources of human infection and are estimated to be responsible for about one-half of the common – vehicle epidemic. Salmonella in feces of infected hens may contaminate the surface of egg shells or penetrate into the interior of the egg through hairline cracks. In hens with ovarian infection, organism may gain access to the yolk. Meat, especially beef and pork, are quite often implicated, accounting for about 13 % of the outbreaks, and dairy products, including raw and powdered milk account for about 4 % of the epidemics.
Cross – infection with spread by person – to – person is responsible for virtually all the outbreaks ieonatal nerseries and in pediatric wards and is important in many outbreaks among hospitalized adults.
The stage is set for cross-infection when Salmonella are introduced into the hospital by admission, or for example, a patient with acute enterocolitis or as asymptomatic carrier with other medical problem or by the introduction of a contaminated common- course vehicle. Hospital personnel then may carry infection on hands or clothing from patient to patient; in some cases fomites (dust, delivery room, furniture), may be implicated in transmission. Hospital personnel who are excreting Salmonella in stools may also occasionally transmit infection to patient.
Pathogenesis
The development of disease after ingestion of Salmonella is influenced by the number and virulence of the organisms and by multiple host factors.
A large number of Salmonella must be swallowed in most instances to produce disease in healthy human being. However, in the event of infection with unusually virulent organisms or in patients with reduced resistance, symptomatic infection may result from extremely small inocula. Ingested organisms pass from the mouth to the stomach. In the stomach Salmonella are exposed to gastric acid and low PH, which reduce the number of viable organisms. Most Salmonella are perished rapidly at 2,0 PH, which is readily achieved in the normal stomach. Viable bacilli that survive then pass into the small intestine, where the organisms may be further reduced iumber or eliminated entirely. The antimicrobial activity observed in the small bowel is related at least in part to the normal microbial flora of the intestine, which elaborate short-chain fatty acids and perhaps other substances capable of killing or inhibiting growth of Salmonella. Studies in animals have shown that the increased susceptibility to Salmonella infection produced by administration of antibiotics rapidly reverts to normal with reestablishment of the normal intestinal flora.
Salmonella that survive the antibacterial mechanisms in the stomach and upper small bowel may multiply in the small intestine. Multiplication of Salmonella in the intestinal tract may be asymptomatic, associated only with transient excretion of organism in stools, or symptomatic, associated with clinical manifestations of either enterocolitis (acute gastroenteritis) enteric fever or bacteremia.
Blood stream invasion, which occurs with variable frequency, may lead to localization of infection and suppuration at almost any site.
Local factors in the stomach and upper intestinal tract are important determinants of the disease. Factors that neutralize the low PH of the stomach or decrease the time the pathogen is exposed to stomach acid diminish local bactericidal action and increase the probability that an infections inoculums will reach the small intestine. The importance of gastric acidity as a defense mechanism is emphasized by the increased incidence of severe Salmonella enterocolitis in persons with achlorhydria, prior gastroectomy, gastroenterostomy, or vagotomy, conditions that reduce acidity or cause faster gastric emptying time.
The oral administration of buffering compounds also increases susceptibility to intestinal infection. It has been suggested that ingestion of organisms in food allows for longer exposure to gastric acid, thereby necessitating the presence of a relatively larger inoculums to produce disease, whereas water or other liquids, which have a fast gastric transit time, may be less heavily contaminated and still cause disease.
The small intestine provides other protective mechanisms through motility and normal flora. Alteration of the intestinal flora by antibiotics markedly reduces the size of the inoculums required to produce Salmonella infection in animals and humans and prolongs the convalescent carrier state. Prior antimicrobial therapy also enhances the possibility of infection with antibiotic – resistant Salmonella strains.
Age is an important determinant of disease produced by Salmonella. Salmonella enterocolitis occurs with highest incidence in children less than 5 years old; newborns and infants less one year of age are especially susceptible. The influence of age on incidence may reflect immaturity of humoral and cellular immune mechanisms, diminished antibacterial action of the normal intestinal flora, a high frequently of fecal – oral contamination, or other factors. In some instances, increasing resistance with age is related to immunity consequent to previous exposure to the organism, even though disease has not been produced.
Patient with impaired cellular and humoral immune mechanisms are at increased risk for development of Salmonellosis. Impairments of host defenses caused by malnutrition, malignancy, infection with human immunodeficiency virus or therapeutic measures such as corticosteroid or immunosuppressive therapy also predispose to infection and disease.
Salmonella causing enterocolitis are thought to produce diarrhea by a true infection with mucosal invasion and possibly by elaboration of an enterotoxin that acts on upper intestinal transport. Salmonella invasion of intestinal mucosa may lead to local production of inflammatory exudates of mediators that stimulate electrolyte secretion and smooth muscle contraction (Fig.10).
Fig.10. Flask-shaped ulcer with necrosis of epithelium and extrusion of necrotic tissue, fibrin and mucus
There are two types of toxins: exotoxins and endotoxins. Exotoxins are the toxic products of bacteria which are actively secreted into environment. Endotoxins are toxic substances which are liberated only during the lysis of microbial cells. The principal factor responsible for development of this disease is endotoxical complex of Salmonella, but we should remember that these bacteria produce even exotoxins. Exotoxins and endotoxins have toxical properties.
Stages of salmonellosis development:
1. Colonization (setting) of pathogenic organism in the place of the inculcation.
2. Invasion and reproduction.
3. Death of the pathogenic bacteria and endotoxins liberation.
Infectious process may stop at the stage of colonization due to unknown reasons. Invasion may be limited by nearest tissues. In majority cases it leads to development of gastrointestinal forms of Salmonellosis. For development of the first stage of pathogenesis of Salmonellosis the factors violating structural and functional state of gastrointestinal tract play important role (dysbacteriosis, hypovitaminosis and other). These conditions may promote to development of the disease even due to small quantity of bacteria in food-stuffs.
In salmonellosis the principal pathologoanatomical changes develop in the place of inoculation of the agent in the small intestine. Data about changes of small intestine in gastrointestinal forms of Salmonellosis may be received only as a result of its biopsy. But biopsy is not used in practice. Investigation of material during biopsy testifies dystrophical changes of epithelium, infiltration of epithelium of mucous membrane by macrophages. Increased quantity of interepithelial leukocytes, polymorphonuclear leukocytes and macrophages is marked.
Principal changes develop in lamina propria of mucous membrane of small intestine in Salmonellosis. These changes are accompanied by hyperemia, hemorrhages, edema and intensification of cell infiltration. At the same time the changes of the different parts of gastrointestinal tract develop. There is an acute inflammatory process, dystrophic changes of epithelium, edema, hyperemia and cell infiltration in stomach. There are dystrophy, erosions, hyperemia, edema in mucous of large intestine. Changes in all parts of gastrointestinal tract are transient. They are exposed to reverse development in clinical recovery of the patients.
In half of the patients with Salmonellosis nonsharp violations of liver are marked. These changes are considered as compensatory mechanism.
In connection with sufficient efficiency of modern methods of treatment the fatal outcomes are rare. Dystrophic changes of parenchymatous organs were revealed in autopsy of deceaseds from gastrointestinal forms of Salmonellosis. These changes were direct cause of death. Inrarely, edema of the lungs and brain, hyperplasia of spleen and mesenteric lymph nodes may develop.
The transmission of salmonellae to a susceptible host usually occurs via consumption of contaminated foods. The most common sources of salmonellae include beef, poultry, and eggs. In one recent estimate, consumption of egg shell fragments contaminated with S enteritidis was responsible for approximately 182,060 cases of enteritis in the United States in the year 2000. Improperly prepared fruits, vegetables, dairy products, and shellfish have also been implicated as sources of Salmonella.
In the spring of 2008, 1442 persons across 43 states developed infection with S enterica serotype Saintpaul, with the same genetic fingerprint linking contaminated jalapeno and serrano peppers as a source of infection. Almost any type food product could serve a source for infection, including peanut butter, as seen during a recent outbreak of more than 600 cases. Powdered infant formula has been implicated in two consecutive large outbreaks of S enterica serotype Agona among infants in France.
In addition, human-to-human and animal-to-human transmissions can occur. For example, amphibian and reptile exposures are associated with approximately 74,000 Salmonella infections annually in the United States. Salmonellosis outbreaks have also been associated with handling chicks, ducklings, kittens, and hedgehogs. Recently, a study of 28 cases of Styphimurium identified pet rodents as a previously unrecognized source of human Salmonella infection.
Although the infectious dose varies among Salmonella strains, a large inoculum is thought to be necessary to overcome stomach acidity and to compete with normal intestinal flora. Large inocula are also associated with higher rates of illness and shorter incubation periods. In general, about 106 bacterial cells are needed to cause infection. Low gastric acidity, which is common in elderly persons and among individuals who use antacids, can decrease the infective dose to 103 cells, while prior vaccination can increase the number to 109 cells.
After ingestion, infection with salmonellae is characterized by attachment of the bacteria by fimbriae or pili to cells lining the intestinal lumen. Salmonellae selectively attach to specialized epithelial cells (M cells) of the Peyer patches. The bacteria are then internalized by receptor-mediated endocytosis and transported within phagosomes to the lamina propria, where they are released. Once there, salmonellae induce an influx of macrophages (typhoidal strains) or neutrophils (nontyphoidal strains).
The Vi antigen of S typhi is important in preventing antibody-mediated opsonization and complement-mediated lysis. Through the induction of cytokine release and via mononuclear cell migration, S typhi organisms spread through the reticuloendothelial system, mainly to the liver, spleen, and bone marrow. Within 14 days, the bacteria appear in the bloodstream, facilitating secondary metastatic foci (eg, splenic abscess, endocarditis). In some patients, gallbladder infection leads to long-term carriage of S typhi or S paratyphi in bile and secretion to the stool. As a rule, infection with nontyphoidal salmonellae generally precipitates a localized response, while S typhi and other especially virulent strains invade deeper tissues via lymphatics and capillaries and elicit a major immune response.
Virulence factors of salmonellae are complex and encoded both on the organism’s chromosome and on large (34-120 kd) plasmids. Some areas of active investigation include the means by which salmonellae attach to and invade the intestine, survive within phagosomes, effect a massive efflux of electrolytes and water into the intestinal lumen, and develop drug resistance. Several Salmonella pathogenicity islands have been identified that mediate uptake of the bacteria into epithelial cells (type III secretion system [TTSS]), nonphagocytic cell invasion (Salmonella pathogenicity-island 1 [SPI-1]), and survival and replication within macrophages (Salmonella pathogenicity-island 2 [SPI-2], phoP/phoQ).
The severity of illness in individuals with salmonellosis is determined not only by the virulence factors of the infecting strain but also by host properties. In a recent study of 129 nonfecal Salmonella isolates at the Massachusetts General Hospital, the most common risk factors were found to be corticosteroid use, malignancy, diabetes, HIV infection, prior antimicrobial therapy, and immunosuppressive therapy.
Sickle cell disease, malaria, schistosomiasis, bartonellosis, and pernicious anemia have been mentioned in the literature as other comorbidities that predispose to salmonellosis. Infants are at a high risk of developing CNS infection as a result of Salmonella bacteremia. Specific anatomical sites, such as an altered urinary or biliary tract, atherosclerotic aorta, or endovascular devices may facilitate persistent focal Salmonella infection.
Clinical manifestations
http://www.bettermedicine.com/article/salmonella-infections
In connection with considerable variability of clinical duration of Salmonellosis there are multitude classifications of this disease. The next classification is more comfortable for practice use:
1) Localized (gastrointestinal) forms of Salmonellosis:
a) Gastritic variant;
b) Gastroenteritic variant;
c) Gastroenterocolitic variant.
2) Generalized forms:
a) Typhus-like form;
b) Septic form (septicopyemia).
3) Carrier state:
a) Acute carriers;
b) Chronic carriers;
c) Transitory carriers.
Clinical symptoms of Salmonellosis are studied sufficiently completely. Gastrointestinal forms of Salmonellosis are observed in most of cases of the disease. According data of different authors they occur from 79 to 85 %.
Incubation period is from 4-6 hours up to some days. Onset of the disease is an acute. Prodromal period is not typical or very short. Weakness, malaise, and slight chill characterize it. Then temperature increases to subfebrile in moderate and severe forms accordingly.
After ingestion of contaminated food or water, illness begins in many patients with nausea and vomiting; these symptoms usually resolve within a few hours. Myalgia and headache are common. The cardinal manifestation is diarrhea, which may vary from a few loose stools to fulminate diarrhea. In most cases, stools are loose, of moderate volume, without blood, swamp-like and bed smell (Fig.11).
Fig.11. Stool in case of salmonellosis
In exceptional cases, the stools may be watery and of great volume (“cholera-like”), or, in other instances, of small volume and associated with tenesmus and gross blood (“shigellosis-like”). Temperature elevations to 38-39 °C are common, as are chills; both appear in the majority of patients in whom definitive diagnosis is established. Abdominal cramps occur in about two-thirds of the patient and are often localized to the periumbilical region or lower abdominal quadrants. Bowel sounds are increased and abdominal tenderness is present. At microscopic examination, stool show a moderate number of polymorphonuclear leukocytes and, occasionally, red blood cells. Cross blood is unusual but may be seen in severe cases. Peripheral leukocyte count is usually normal, although neuthrophilia with a shift to younger forms may be present.
The duration of fever is less than 2 days in the majority of cases. Diarrhea usually persists less than 7 days, although, rarely, gastrointestinal symptoms may last for several weeks. Prolonged fever and diarrhea suggest a complication or a different diagnosis.
Localization of pain in the right lower quadrant of the abdomen in patients with enterocolitis may lead to a diagnosis of acute appendicitis. At surgery, such patients may have normal appendices or occasionally acute appendicitis rarely with perforation.
Clinic of Salmonellosis is characterized by symptoms of damage of cardiovascular system. The basis of these violations is water-electrolytes loss and change of reological properties of the blood.
Changes in organs of respiratory systems are not typical for uncomplicated cases of gastrointestinal forms. But sometimes breathlessness may be observed.
Toxicosis takes place when localized forms of Salmonellosis. It is manifested by headache, pain in the muscles, mild ataxia, asymetric reflexes. Development of toxic encephalitis is possible.
Electrolyte and water depletion may be severe during illness, leading to hypovolemic shock. The disease is more severe in children, in seniors, and in patient with achlorhydria, gastroectomy, gastroenterostomy, sickle cell anemia, or other conditions that impair resistance to infection. The frequency of transient bacteremia is less than 5 % in adults. It is increased in children and in persons with severe preceded diseases. Bacteremia has been shown to occur in 8-16 % of infants and children of 3 years age or younger who are hospitalized with Salmonella enterocolitis. Salmonella intestinal infections has tendency to be prolonged in children, who continue to excrete agent in stool for a longer time than adults after subsidence of clinical manifestation of infection.
Salmonella enterocolitis may develop in hospitalized patients. The illness may be a nosocomial infection or it may result of activation of pre-existing asymptomic intestinal infection by antimicrobial therapy, of surgical diseases of abdomen or from other causes.
In one-two third of children over 5 years and adults positive cultures are observed during second or third week from the onset of the disease. In this time majority of the patients have no symptoms of the disease.
Salmonella can produce an illness characterized by fever and sustained bacteremia without manifestations of enterocolitis. This syndrome may be caused by any Salmonella serotypes. The clinical syndrome of Salmonella bacteremia is characterized by a hectic febrile course lasting for days or weeks. The organism is isolated from blood, but stool cultures are often negative. More than 70 % of cases of generalized forms of Salmonellosis begin as gastrointestinal form with dyspeptic manifestations. Then, in typhus like variant after subsidence of dyspeptic manifestations the disease acquires signs of typhus infection. The second febrile wave-like or incorrect type continues in most cases during 10-14 days. The principal symptoms of the period of climax of the disease are weakness, adynamia, severe headache, sleeplessness, pains of muscles and joints.
Typical typhus state is not characteristic for this variant of Salmonellosis. In majority of the patients enlarged liver and spleen, distantion of abdomen are observed.
Approximately, in 25 % of the patients scanty rose sports are observed. Rash appears on 4-10 day, sometimes later. In peripheral blood leukocytosis is observed only in early period of the disease. Then leukopenia is marked, but with neutrophilosis. Sometimes typhus like variant may be without appearances of gastroenteritis. The principal symptoms of beginning period in that cases are fever, chill, headache, weakness. In the period of climax adynamia, pale skin, injections of scleras are observed.
There are single rose spots on the skin of abdomen and chest. In this variant of generalized form of Salmonellosis relapses may observed, and rarely, complications, which are typical for typhus fever. Typhus like variant may be with temperate manifestations of intoxication and dyspeptic appearances, with short duration fever. There is marked catarrh, hyperemia of pharynx, laryngotracheobronchitis in these patients rarely.
Septic variant (septicopyemia) is sepsis of Salmonella etiology. The development of sepsis is evoked by sharp decrease of the immuneprotective strengths of the organism of the patient. This variant of generalized of Salmonellosis is characterized by acyclic development of the disease, prolonged fever, chills, sweating, hepatosplenomegaly, sometimes development of jaundice, plural purulent metastases in different organs and tissues.
Usually, the disease begins from manifestations of gastroenteritis. Then typical septicopyemia develops with hectic fever. The signs of influence of intoxication on central nervous system are marked from the first days of the disease. They are manifested by irritation, violations of sleep, motive trouble, sometimes delirium. The skin is pale. Rash may appear on the skin (petechias or large hemorrhages).
The secondary purulent focuses may be in any organs and tissues. Localization of infection may be in thyroid, brain membranes, bones, heart, lungs, kidneys, adrenals, pancreas, spleen, liver, pericardium and soft tissues.
Meningitis is a rare complication of Salmonella infection and occur almost exclusively in infants, particularly neonates. Even epidemics of meningitis have been reported during outbreaks of Salmonella infection in hospital nurseries. Clinical manifestations are the same as those of any bacterial meningitis in this age group. The clinical course is usually long and marked by relapse. Acute neurologic complications are common and include subdural empyema, cerebral abscesses, and ventriculitis. Acute or chronic hydrocephalus may occur. Mortality is high, despite appropriate antimicrobial therapy.
Pleuropulmonary disease. Pneumonia or empyema, the predominant types of serious respiratory diseases, occur usually in elderly patients or in patients with underlying diseases such as diabetes mellitus, malignancy, cardiovascular disease, or pulmonary disease. Mortality is high.
Arthritis. Salmonella infection may be with localization in major vessels, including the thoracic and abdominal aortas, coronary arteries, peripheral arteries. Atherosclerotic intrarenal aortic aneurysms are by far the most common vascular sites of localization. The risk of endothelial infection is high in persons over the age of 50 years who have Salmonella bacteremia.
The mechanism of arterial infection is through to be direct implantation at a site of endothelial injury in the bacteremia patient on to extension from an adjacent inflammatory lesion, such as vertebral osteomyelitis. Mortality is high.
Osteomyelitis and Arthritis. Osteomyelitis can develop iormal bone but especially likely to occur in patient with sickle – cell hemoglobinopathies, systemic lupus erythematosus, immunosuppressive therapy, bone surgery or trauma. Salmonella, not Staphylococcus, is the most common cause of osteomyelitis in patients with sickle-cell anemia.
Salmonella may cause a metastatic supportive arthritis. Pyogenic arthritis is much less frequent than reactive arthritis.
Splenic Abscess and Hepatic Abscess. Splenic abscess is a rare complication of Salmonella infection. Localization occurs after bacteremia in posttraumatic subcapsular hematomas or splenic cysts. The clinical manifestation is one of left upper quadrant tenderness, fever and leukocytosis.
Salmonella liver abscesses may occur. Usually, the patients have pre- existing liver disease including amebic abscesses, ecchinococcal cysts, and hematomas. Association with biliary tract disease exists in occasional cases.
Urogenital Tract. Salmonella in stools of carriers or persons with acute illness may gain access to the urinary tract to produce cystitis or pyelonephritis. Localization of Salmonella blood form with abscess formation in kidneys, testicles, or ovaries is also occasionally reported.
Bacteriocarriering of Salmonella is developed after disease. There are acute, chronic and transitory carriers. Acute and chronic carriers are divided depending on duration of excretion of Salmonella. Acute carrier has the duration of excretion of Salmonella from 15 days till 3 months after clinical recovery. The persons, excreting Salmonella over a year, are chronic carriers. The conditions of development of transitory carrier are insignificant dose of the agent and its avirulence.
Complications and outcomes
Complications and outcomes of Salmonellosis, as and multiple clinical forms are exposed to wide oscillations. Even gastrointestinal forms of Salmonellosis with favorable duration are not finished clinical recovery.
Generalized form of Salmonellosis, as rule, is accompanied by complications. Exceeding expression of symptoms of Salmonellosis frequently leads to collapse (1.5-6 % of the cases). Collapse may develop at the first day of the disease on the altitude of clinical manifestations before dehydration. Endotoxinemia plays leading role in development of collapse. It is a manifestation of infectious-toxic shock.
Besides expressive hypodynamic disorders acute renal insufficiency, edema of brain, edema of lungs and hemorrhagic syndromes develop. The development of dysbacteriosis is connected with large doses of antibiotics use at any clinical forms of Salmonellosis. Dysbacteriosis may be compensated or latent.
Outcomes of salmonellosis depend on premorbidal state, age, clinical forms, timely diagnostics and treatment.
Diagnosis
Diagnostics of salmonellosis is performed on the basis of epidemiological, clinical and laboratory data. Bacteriological and serological methods are used for confirmation of salmonellosis. The main materials for bacteriological investigation are vomiting masses, water after irrigation of stomach, stool, blood, urine.
Serological investigations are used. These are reaction of agglutination (RA) (7-8th day of the disease) and indirect hemagglutination (RIHA). RIHA is more sensitive. It gives positive results on the 5th day of the disease. Diagnostical titer is 1:200. Serological investigation should be done in dynamics of the disease.
Rentgenology investigation shows the increasing of thick intestin (Fig.12).
Fig.12. Tension and swelling of sigmoid colon
Differential diagnosis
Differential diagnosis of salmonellosis is perform with other intestinal diseases – shigellosis, toxic food-borne infections, esherichiasis, cholera; with surgical diseases – appendicitis, pancreatitis, cholecyctitis, thrombosis of mesenterial vessels; gynecological pathology and with therapeutic pathology (myocardial infarction, chronic gastritis aggravation, enterocolitis, ulcerous disease), with acute gastroenteritis of viral origin (enteroviral, rotaviral etiology), poisoning by organic and inorganic poisons, poisoning by mushrooms.
Generalized forms of salmonellosis is necessary to differentiate from sepsis of different etiology, pneumonia, malaria, acute pyelonephritis, tuberculosis.
- Modern blood culture systems are 80%-100% accurate in detecting bacteremia. As the disease duration increases, the sensitivity of blood cultures decreases, while the sensitivity of stool isolation increases.
- Freshly passed stool is the preferred specimen for isolation of nontyphoidal Salmonella species. Since stool carriage of S typhi may be prolonged, the interpretation of positive results merits caution, and the diagnosis should be established only when accompanied by clinical findings that are typical of infection.
- Bone marrow aspirate and culture is superior to blood culture, since the bacterial concentration in bone marrow is 10 times that of peripheral blood. In patients who received antibiotic therapy prior to hospitalization, bone marrow aspirate may still be positive for Salmonella even if blood culture results are negative.
- In cases of typhoid fever, S typhi or S paratyphi may also be isolated from urine, rose spot biopsy, or gastric or intestinal secretions.
- Grouping of Salmonella isolates is usually performed with polyvalent antisera specific for O and Vi antigen. S typhimurium belongs to group B; S enteritidis and S typhi belong to group D.
- Salmonellosis is a reportable disease in the United States.
Hematology and chemistry
- Although the WBC count is usually within the reference range in patients with salmonellosis, approximately one fourth of patients with typhoid fever are leukopenic, neutropenic, or anemic. Thrombocytopenia is neither universal nor diagnostic.
- The eosinophil count and sedimentation rate are typically low. A high sedimentation rate suggests abscess formation or osteomyelitis. Eosinophilia should prompt a search for concomitant parasitic infection.
- Mild hepatocellular liver function abnormality is common.
Treatment
http://emedicine.medscape.com/article/228174-treatment
The volume of medical actions depends on the clinical form and a stage of gravity of disease. At gastrointestinal form immediately wash out stomach and intestine with boiled water (isotonic solution of Sodium chloridum is the best) then give sorbents per os and give a warm drink. For restoration of hydro-electrolityc balance and normalization of circulatory disorders there should be indicated per os Glucosole or Rehydroni. Infusion therapy is indicated at expressed dehydration – Trisol, Quartasol, Lactasol. At severe stage of dehydratation one of the specified solutions is infused in vein with rate 80-120 mL/min, 5-10 L of solution is necessary on course of treatment. If hypotension and toxicosis are marked Prednisolon and Hidrocortizon, Polyglucin, Reopoliglycin are infused in vein. Pathogenetically 5 % solution of glucose is indicated with desintoxication purpose and restoration of power balance, a solution of sodium hydrocarbonat for acidosis correction, Heparin for improvement of reologic properties of blood, preparations of antiallergic action – calcii chloridi, Dimedrol, Tavegil, Indomethacin are proved at severe diarrhea (for downstroke of Prostaglandines synthesis), calcium gluconate. Antibiotics at gastrointestinal form of salmonellosis are not used.
However at syndrome of hemocolitis and lingering diarrhea Furazolidon is indicated in combination with fermental preparations – Festal, Panzynorm, Pancreatin, Mezym forte, Pancitrat, Vobensim. The broths of herbs has anti-inflammatory, disinfectant and astringent properties, and also properties raising organism reactivity. They are vitamin preparations, Pentoxyl, Methyluracil, Thymalin, Enterol-250 also indicated. Bificol, Colibacterin, Bifidumbacterin, Linex is used at intestinal dysbacteriosis.
At generalized form simultaneously with pathogenetic therapy there are indicated antibiotics – Levomycetin, Ampicillin, Monomycin, Gentamycini sulfas, Cefazolin (Kefzol), Cefotaxim (Claforan). At the septic form of disease antibiotics are better to infuse parenteraly. For sanitation of chronic carriers of salmonelas the specified antibiotics use in average therapeutic doses in combination with preparations stimulating nonspecific and immunological reactivity (Pentoxyl, Methyluracil, Splenin, Thymalin, T- activin).
Prophylaxis
The measures of prophylaxis are veterinary-surveillance upon animals and production of meat and dairy industry, laboratory control of food stuffs.
It is necessary to reveal carriers on milk farms, in foods, children’s and medical establishments. The maintenance of the rules of personal hygiene and rules of food’s cooking plays an important role in prophylaxis of Salmonellosis.
Food poisoning
Toxic food-borne infections is an acute transitory disease, caused by conditionally pathogenic bacteria. These bacteria are capable to produce exotoxin (in food-stuffs). The disease is accompanied with symptoms of the damage of the upper parts of the gastrointestinal tract (gastritis, gastroenteritis) and by violation of the water-electrolyte balance.
Etiology
Many types of the conditionally pathogenic bacteria may be agents of the toxic food-borne infections and produce exotoxin out of the human organism on the different food-stuffs. Enterotoxins (thermoliable and thermostable) increase the secretion of the fluids and salts into the stomach and intestine. Cytotoxins damage the membranes of the epithelial cells and violate the protein synthetic processes. The agent, producing enterotoxins are Clostridium perfringeus, Proteus. vulgaris, Proteus mirabilis, Bacillus cereus. These enterotoxins are also formed by agents from the in families of Klebsiella, Enterobacter, Citrobacter, Serrafia, Pseudomonas, Aeromonas, Edwarsiella. The majority of these enterotoxins are thermoliable.
Epidemiology
Pathogenic organisms of the toxic food infections are widely spread in the nature. They may be everywhere: in the fecal matters of human and animals; in and the soil; in the water; in an air and on the different subjects. The way of the spread of the infection is alimentary. The factors of the transmission of the disease are solid products (sausages, eggs, meat and fish canned food) and liquid products (soup, milk, juices, compotes, jellies, lemonade, beer, cocktails). They are the nutritive mediums for bacteria.
The susceptibility to this group of diseases is very high, sometimes till 90-100 %. The typical sign of the toxic food-borne infections is not only group but explosive character of illness due to all participants of the outbreak become ill during a short period (over a few hours). The diseases toxic food-borne infections are registered during the hole the year, but especially in summer.
Pathogenesis
In toxic food infections exotoxin is contained in food, besides bacteria. Due to this the incubation period is very short. Time of the of clinical manifestations development after influence of toxins to the mucous membrane is from 30 minutes till 2-6 hours.
Pathogenesis and clinical manifestations of the disease depend of the type and dose exotoxin, and also from other toxical substances microbial origin, containing in the food-stuff. Enterotoxins (thermoliable and thermostable) are connected with the epithelial cells of stomach and intestine and act to the fermental system of the epitheliocytes, but no cause morphological changes in these organs. Enterotoxin activates ferments adenylcyclase and guanylcyclase increasing formation of the biological active substance (cyclic adenosinemonophosphates and cyclic guanidinmonophosphates) in the cells of the mucous membranes. All these changes lead to the increase rate of secretion of water and salts into the stomach and intestine and to the development of diarrhea and vomiting.
Pathological anatomy
Cytotoxins damage the membranes of the epithelial cells and violates synthetic processes. It may increase the permeability of the intestinal wall for different types of the toxical substances, and for oneself microorganisms, development of intoxication and violation of microcirculation and localized inflammatory alterations of the intestinal mucous membrane.
Clinical manifestations
The clinical manifestations of the toxic food-borne infections caused by only enterotoxins are less severe. In the majority of the cases of the disease there is no fever and just considerable inflammatory changes of the mucous membrane of the stomach and intestine.
The course of the disease become more severe due to accumulation of enterotoxin and cytotoxin in the food-stuffs. The high fever and considerable change of the mucous membrane of the gastrointestinal tract are observed.
In toxic food-borne infections there is combination of the signs of the damage of the gastrointestinal tract (gastritis, gastroenteritis or gastroenterocolitis) and signs of the general intoxication and dehydration. The incubation period is from 30 minutes to 24 hours (generally 2-6 hours). The beginning of the disease is an acute. At first the nausea occurs. Frequently the replated, agonizing and unrestrained vomiting occurs. Almost at the same time with vomiting the diarrhea starts. Stool is watery from 1 to 10-15 times a day. In considerable part of patients the disease is not accompanied by severe pain in the stomach and increase of the body temperature of the body. However the disease may be with spasmatic pains in the stomach, with the raise of the body temperature upto 38-39 °C. The raise of the body temperature takes place at the early hours of the disease and through 12-24 hours the temperature is reduced to normal.
During objective examination of the patients the pale skin, sometimes cyanosis, cold extremities are observed. The tongue is coated. Stomach is soft and painful in the epigastrium during palpation. The cardiovascular system also suffers. There is bradycardia (during hyperthermia – tachycardia). The arterial pressure decrease. In some cases collapse of short duration develops. Due to repeated vomiting and plenty diarrhea the signs of dehydration develop. It may be possible of the appearance of the muscle’s cramps of extremities, decrease of the diuresis and reduced turgor of the skin. The liver and pancreas are not expanded. In hemogram leukocytosis, neutrophylosis and temperate accelerate ESR are noted.
The duration of the disease in majority of the cases is 1-3 days. The toxical food infection may be accompanied by severe complications. Hypovolemic shock and an acute heart insufficiency, connecting with violations of electrolytic balance (hypokalemia) are observed.
Diagnosis
The diagnosis of the toxic food-borne infections is made according the results of the clinical symptoms estimation, epidemiological and laboratory data. The typical signs are the impetuous development of the disease after short incubation period, presence of symptoms of gastritis, gastroenteritis or gastroenterocolitis in combination with intoxication, dehydration, disposition to the vascular dystonia.
It is necessary to consider the simultaneous disease of the group of the persons, use one itself food-stuff, the features of this product, sanitary-hygienic state of commercive institutions, public nutrition when taking epidemiologic data. It is necessary to reveal the sick men or bacteriocarries among personnel of these institutions, because they may be a source of infection of the food.
Materials for bacterial examination are suspicious food products, vomitory masses, water after irrigation of the stomach, stool of the patient. Serological methods does not have independent meaning in the diagnostics.
Differential diagnosis
Differential diagnosis of toxical food infection is performed with acute intestinal infections (cholera; acute shigellosis; gastrointestinal form of yersiniosis; rotoviral gastroenteritis; campylobacteriosis; dyspeptic variants of preicteric period of viral hepatitis and others), with surgical diseases (acute appendicitis; cholecystopancreatitis; thrombosis of mysentrical vessels; perforation of ulcers in the stomach and duodenum), with gynecological diseases (ectopic pregnancy; toxicosis of the pregnancy), with therapeutic diseases (myocardial infarction; hypertension crisis), with neurological diseases (acute damages of cranial blood circulation, subarachnoidal hemorrhage), with urological diseases (pyelonephritis; acute renal insufficiency). During the diagnostics it is necessary to consider the food poisoning; poisoning by mushrooms; salts of hard metals.
Treatment
It is necessary to wash out a stomach and intestine to release them from microbes and toxins as soon as possible. For a lavage it is better to use isotonic solution of Sodium chloridum, boiled water or 1-2 % solution of sodium hydrocarbonate. Then give inside the activated microspherical coal (SKN brand). Alternative preparations are Sillard P, Smecta, Enterodes and other enterosorbents. Their early indication promotes the fastest improvement of health state, preserves intoxication, development of the serious form of bacterial endotoxicosis. In case of development of infection-toxic shock we should immediately infuse in blood colloid and cristaloid solutions: Polyglucin, Reopoliglycin, donor Albumin, Trisol, Acesol, Quartasol, and also glucocorticoides.
Etiotropic treatment is indicated only at serious forms with development of colitic syndrome: Furazolidon or Enteroseptol. Antibiotics are indicated in case of development of sepsis – Levomycetin, Gentamicin, Ampicillin, Ofloxacin (Tarivid).
Prophylaxis
Prophylaxis of the toxical food infection is concluded in prevention of infection of the food-stuff, of the reproduction of the microorganisms in the food. It is necessary to keep the food-stuffs and prepared food at the temperature from 2 till 4 ºC.
The mechanization and automatization of the food objects, the elaboration of the new methods of the preserving and storage of the food-stuff, the freezing at low temperature are conductive to the successful prophylaxis of the toxical food infection.